ARCHIVES

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

This article is from The Cancer Letter archive.

Vol. 10 No. 14 | April 6, 1984

Download PDF Visit The Full Archive

Related Articles

US Oncology To Participate In Firm’s Ovarian Cancer Trial.

January 26, 2001

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

May 2, 2008

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

June 24, 2005

NCAB Approves CCP, Agrees To Compromise On Including Control

May 21, 1982

NCI Begins TAILORx Study.

May 26, 2006